Cagrilintide CAS 1415456-99-3 for Weight Loss

Enhance satiety and regulate postprandial glucose levels.
CagriSema (cagrilintide + semaglutide) reduced body weight by 15.6% over 32 weeks in overweight/obese patients with type 2 diabetes, outperforming semaglutide alone (5.1%)